Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity.

Publisher Website
Google Scholar
Abstract
The human immunodeficiency virus (HIV) integration protein, a potential target for selective antiviral therapy, was expressed in Escherichia coli. The purified protein, free of detectable contaminating endonucleases, selectively cleaved dobule-stranded DNA olgonucleotides that mimic the U3 and the U5 termini of linear HIV DNA. Two nucleotides were removed from the 3'' ends of both the U5 plus strand and the U3 minus strand; in both cases, cleavage was adjacent to a conserved CA dinucleotide. The reaction was metal-ion dependent, with a preference for Mn2+ over Mg2+. Reaction selectivity was further demonstrated by the lack of cleavage of an HIV U5 substrate on the complemetary (minus) strand, and analogous substrate that mimics the U3 terminus of the avian retrovirus, and an HIV U5 substrate in which the conserved CA dinucleotide was replaced with a TA dinucleotide. Such an integration protein-mediated cleavage reaction is expected to occur as part of the integration event on the retroviral live cycle, in which a double-stranded DNA copy of the viral RNA genome is inserted into the host cell DNA.